Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Avinger Inc

AVGR
Current price
2.27 USD -0.33 USD (-12.69%)
Last closed 2.6 USD
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 4 468 354 USD
Yield for 12 month +304.20 %
1Y
3Y
5Y
10Y
15Y
AVGR
21.11.2021 - 28.11.2021

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California. Address: 400 Chesapeake Drive, Redwood City, CA, United States, 94063

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5 USD

P/E ratio

Dividend Yield

Current Year

+7 652 000 USD

Last Year

+8 273 000 USD

Current Quarter

+1 859 000 USD

Last Quarter

+1 906 000 USD

Current Year

+2 003 000 USD

Last Year

+2 654 000 USD

Current Quarter

+343 000 USD

Last Quarter

+374 000 USD

Key Figures AVGR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -17 166 000 USD
Operating Margin TTM -273.75 %
PE Ratio
Return On Assets TTM -58.49 %
PEG Ratio
Return On Equity TTM -973.16 %
Wall Street Target Price 5 USD
Revenue TTM 7 623 000 USD
Book Value -2.56 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -1.5 %
Dividend Yield
Gross Profit TTM 2 654 000 USD
Earnings per share -15.1 USD
Diluted Eps TTM -15.1 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -251.78 %

Dividend Analytics AVGR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AVGR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 13.09.2023
Dividend Date 24.06.2019

Stock Valuation AVGR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.2109
Price Sales TTM 0.8884
Enterprise Value EBITDA -1.035
Price Book MRQ 1.5635

Financials AVGR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AVGR

For 52 weeks

2.27 USD 18 USD
50 Day MA 3.49 USD
Shares Short Prior Month 23 693
200 Day MA 4.2 USD
Short Ratio 1.86
Shares Short 16 035
Short Percent 1.73 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds


S

SX7EEX

14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics